Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jonathan Price

Physician Assistant Saint Louis, MO Physician Assistant

NPI 1548612062 CMS profile 10997799

607 S New Ballas Rd Ste 3100, Saint Louis, MO 63141

Open in the dashboard

General payments

$9,546

75 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jonathan Price of Saint Louis, MO is reported in the CMS Open Payments database as having received $9,546 across 75 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,898 22
2024 General $1,099 12
2023 General $1,030 13
2022 General $4,148 21
2021 General $1,370 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jonathan Price
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Jonathan Price were reported at $1,898. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Jonathan Price Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,370 $132 $37–$438 $132
2022 $4,148 $155 $48–$522 $149
2023 $1,030 $167 $52–$557 $160
2024 $1,099 $178 $55–$600 $164
2025 $1,898 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Arthrex, Inc. $4,556 33 payments
  2. Elite Orthopedics, LLC $3,757 19 payments
  3. Stryker Corporation $845 8 payments
  4. Seattle Genetics, Inc. $85 1 payment
  5. Bioventus LLC $84 3 payments
  6. Vertex Pharmaceuticals Incorporated $59 3 payments
  7. Baudax Bio Inc. $42 2 payments
  8. Molnlycke Health Care US, LLC $27 1 payment
  9. Djo, LLC $23 1 payment
  10. Esaote North America, Inc. $21 1 payment
  11. Other $47 3 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Travel and Lodging $4,252 14 payments
  2. Education $3,685 4 payments
  3. Food and Beverage $1,609 57 payments
Products named General payments · program years 2021–2025
  1. MAKO $776 4 payments
  2. TRIATHLON $96 2 payments
  3. XCELL $67 2 payments
  4. INSIGNIA $65 2 payments
  5. JOURNAVX $59 3 payments
  6. Mepilex Border Post-Op Ag $54 2 payments
  7. ANJESO $42 2 payments
  8. PROPHECY $36 2 payments
  9. INFINITY $33 2 payments
  10. CMF $23 1 payment
  11. Other $82 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$2,133

Medicare's payments for the services billed

Medicare patients

23

Average age 69

Services billed

44

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 65%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

75 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record